
Camereyes
Camereyes is dedicated to prviding affordable eyecare and preventing blindness.
Date | Investors | Amount | Round |
---|---|---|---|
$700k | Early VC | ||
Total Funding | 000k |
Related Content
Camereyes is a healthcare technology company specializing in the early detection and monitoring of diabetic retinopathy, a leading cause of blindness among working-age adults. The company operates in the medical device market, targeting diabetes clinics, ophthalmologists, and remote healthcare providers. Its core product, the InSight system, features a low-cost, high-quality, portable nonmydriatic fundus camera mounted in a comfortable headset. This device automatically captures high-quality color and red-free fundus images with over 30 degrees field of view in less than a minute. These images are stored in the cloud for easy access, research, and monitoring.
The business model revolves around selling the InSight system to healthcare providers and offering cloud-based storage and advanced machine learning decision support systems. The company generates revenue through the sale of its camera systems and subscription fees for its cloud services and decision support tools. The system is designed to be user-friendly, requiring no special setup or skills to operate, making it ideal for both urban and remote healthcare settings.
Camereyes leverages technology to enhance patient compliance and prevent blindness by providing quick and accurate test results. Images are automatically forwarded to a network of accredited professional readers who use advanced machine learning systems to analyze the images. Detailed reports are then sent back to the point of care within minutes, facilitating timely treatment and intervention.
Keywords: diabetic retinopathy, fundus camera, portable, cloud storage, machine learning, decision support, healthcare technology, early detection, patient compliance, remote healthcare.